Clinical Trial Update: Geodon (Ziprasidone) for Posttraumatic Stress Disorder [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ziprasidone (Geodon) for posttraumatic stress disorder has completed. The study status is reported as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posttraumatic Stress Disorder

Drugs mentioned

• Geodon (Ziprasidone)

Snippet

Sponsor: Creighton University | Conditions: Posttraumatic Stress Disorder, Post-Traumatic Stress Disorder | Phase 4 | Status: COMPLETED